TickerFactsScreenerDevelopers

Dyne Therapeutics, Inc. (DYN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $14.63M2020: $300.85M2021: $200.82M2022: $172.15M2023: $121.63M2024: $435.45M2025: $893.37M$893.37M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$893.37M+105.2%
2024$435.45M+258.0%
2023$121.63M-29.3%
2022$172.15M-14.3%
2021$200.82M-33.2%
2020$300.85M+1956.1%
2019$14.63M—